Pressmeddelanden från ViroGates

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

ViroGates publishes its financial calendar for 2025

ViroGates publishes its financial calendar for 2025

MFN • 19 Dec 2024 18:08

ViroGates announces financial guidance for 2025

ViroGates announces financial guidance for 2025

MFN • 19 Dec 2024 17:20

ViroGates announces a reorganisation of its marketing and sales department and revises its guidance for the year

ViroGates announces a reorganisation of its marketing and sales department and revises its guidance for the year

MFN • 16 Dec 2024 17:16

ViroGates’ capital raise of DKK 8.2 million and issue of 1,289,510 new shares have been registered

ViroGates’ capital raise of DKK 8.2 million and issue of 1,289,510 new shares have been registered

MFN • 11 Nov 2024 17:05

ViroGates announces its Interim Report for Q1-Q3 2024: Revenues are disappointing, but strategic refocusing will pave the way for future growth

ViroGates announces its Interim Report for Q1-Q3 2024: Revenues are disappointing, but strategic refocusing will pave the way for future gro...

MFN • 07 Nov 2024 12:05

ViroGates announces a distribution agreement with suPAR Health and a directed issue of shares to suPAR Remedy LLC

ViroGates announces an agreement with US-based suPAR Health to distribute its blood test for chronic inflammation within the United States.

MFN • 14 Oct 2024 18:37

ViroGates announces its half-year report for H1 2024: Revenue for the first half-year of 2024 falls behind the same period in 2023 due to lower activity among research customers

ViroGates announces its half-year report for H1 2024: Revenue for the first half-year of 2024 falls behind the same period in 2023 due to lo...

MFN • 15 Aug 2024 12:30

ViroGates announces revised financial guidance for 2024

ViroGates announces revised financial guidance for 2024

MFN • 17 Jul 2024 14:45